CYP cynata therapeutics limited

Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT, page-21

  1. 4,863 Posts.
    lightbulb Created with Sketch. 344
    Well I now own CYP shares once agan. A simple amount in CYP for my portfolio, greater than most perhaps, but not of Sector's standards.

    My usual strategy is in place, to buy more....if the price decreases, at increasing volumes to a set limit that I am prepared to lose.

    With this stock, and how it trades so poorly in volume, my buy awaiting should prove to be a buffer.against it going lower than the current low.

    What the FDA does, re the latest MSB submission ( due on or before August 2 ) , will determine the future of all stem cell based Companies.

    I

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.0¢
Change
0.000(0.00%)
Mkt cap ! $36.15M
Open High Low Value Volume
16.0¢ 16.5¢ 16.0¢ $60.94K 379.9K

Buyers (Bids)

No. Vol. Price($)
5 158709 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 35334 4
View Market Depth
Last trade - 14.38pm 25/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.